Under the title “Understanding Cells to Revolutionize Healthcare”, researchers, political decision-makers, industry leaders and prominent figures of the scientific community will gather in Berlin to discuss strategies to better understand how diseases arise and develop in the human body – cell by cell.
At the opening conference, the LifeTime consortium will present its vision and goals and discuss the state of the art of technologies that form the pillars of the initiative (single cell multi-omics; data science, artificial intelligence and machine learning; experimental disease models such as organoids).
The LifeTime consortium aims to investigate how genomes function in cells, how cells form tissues and organs, and how their activities change dynamically as diseases progress.
The long-term goal of LifeTime is to advance the understanding of diseases, improve early detection and prevention, and develop innovative treatments for chronic and progressive diseases. It is about the precision medicine of the future.
LifeTime is coordinated by Professor Nikolaus Rajewsky at the Max Delbrück Center for Molecular Medicine (MDC) in Berlin and Dr. Geneviève Almouzni at the Institut Curie in Paris. More than 120 leading scientists, over 50 renowned European research institutions from 18 countries and more than 70 companies are involved in LifeTime.
LifeTime Launch Event
• 6 May 2019, from 8:00 a.m. to 10:00 p.m.
• 7 May 2019: 9:00 a.m. to 5:15 p.m.
• bcc Berlin Congress Center GmbH, Alexanderstrasse 11, 10178 Berlin, Germany
Registration and interview requests
To register for the opening conference, interview requests and further information, please contact the LifeTime press team.
Communication Specialist for the LifeTime Initiative
Max Delbrück Center for Molecular Medicine
13125 Berlin-Buch, Germany
+49 30 9406 2136
LifeTime on Social Media